Formula Reformulation
Phase 3 Clinical Trial to Evaluate the Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis
Sponsor study identifier
interventional
0
0 countries
N/A
Study Start
November 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
April 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
May 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The purpose of this study is to evaluate the clinical efficacy of the ophthalmic solution PRO-118 compared with olopatadine hydrochloride ophthalmic solution in allergic conjunctivitis.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 19, 2012
Actual (reported)August 6, 2012
Actual (reported)November 2014
Date type not reportedThis date has not been verified as actual or estimated.
April 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
May 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
conjunctival hyperemia
Change from Baseline in conjunctival hyperemia after 21 days of treatment
day 21
epiphora
day 21
green lissamine dye
day 21
fluorescein dye
day 21
pro-118 ophthalmic solution, instill one drop in each eye once a day for 21 days
Olopatadine Hydrochloride ophthalmic solution 2%, instill one drop in each eye once a day for 21 days
instill one drop in each eye once a day for 21 days
instill one drop in each eye once a day for 21 days
0 participants (actual enrollment reported by the registry).
First Submitted
July 19, 2012
First Posted
August 6, 2012
Study Start
November 2014
Date type not reportedThis date has not been verified as actual or estimated.
Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
April 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
May 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
October 2, 2018
Record last verified: 2018-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: